Project Details
Project Description
In contemporary Australian populations, 15-17% of pregnant women have asthma. Maternal asthma increases the risks of special care unit (SCU)/neonatal intensive care (NICU) admission by 12% and of respiratory distress syndrome by 9% overall (22% within term-born, so the increased risk is not explained by premature delivery). A recent meta-analysis suggests even stronger adverse effects of maternal asthma on the fetus, including a 49% increased risk of neonatal death and 50% increased risk of neonatal hospitalisation.
We will perform a pilot preclinical study to test the first treatment to prevent neonatal lung disease in newborns of asthmatic mothers.
We will perform a pilot preclinical study to test the first treatment to prevent neonatal lung disease in newborns of asthmatic mothers.
Short title | Protecting babies of asthmatic women |
---|---|
Status | Finished |
Effective start/end date | 1/01/20 → 31/12/21 |
Keywords
- fetal development
- lung development
- pregnancy
- maternal
- asthma
- respiratory distress syndrome (RDS)
Equipment
-
Histology Platform
Camilla Cohen (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
MHTP Medical Genomics Facility
Trevor Wilson (Manager)
Hudson Institute - Department of Molecular and Translational ScienceFacility/equipment: Facility